Compliance with the new EU MDR and IVDR

Publish date:

Medical and in-vitro diagnostic device manufacturers must meet strict deadlines over the next three years if they are to implement new compliance strategies without affecting the time to market of new products.

The need to strengthen the regulatory platform across the European Union (EU) is driven by the need to ensure patient safety and device performance. The new Medical Device Regulations (MDR) and In-Vitro Diagnostic Regulations (IVDR) regulations seek to harmonize the regulations to improve transparency and product traceability.

Regulatory changes are an effective step towards enabling the Intelligent Industry. Capgemini helps organizations transition smoothly to the new EU
MDR/IVDR requirements by offering a customized strategic approach, from gap assessment to lifecycle management support.



File size: 523.23 KB File type: PDF

Related Resources

Get The Future You Want

A new brand promise that captures the spirit of Capgemini

Open Insurance Transformation

Maximize the new ecosystem reality and bring innovative products and services to market...


By continuing to navigate on this website, you accept the use of cookies.

For more information and to change the setting of cookies on your computer, please read our Privacy Policy.


Close cookie information